Skip to main content
SpringerLink
Log in

Analysis of Neural Precursor Cells in the Context of Origin of Brain Tumors, Their Treatment, and Repair of Treatment-Associated Damage

  • Chapter
Brain Tumors

Part of the book series: Contemporary Cancer Research ((CCR))

  • 832 Accesses

Abstract

The treatment of any disease always begins with a correct diagnosis. It is here, before any treatment has been initiated, that enormous problems are faced by those involved in investigating brain tumors. Despite longstanding attempts to generate unambiguous diagnostic criteria for tumors of the central nervous system (CNS), the extent of disagreement between neuropathologists diagnosing the same tumor is often considerable (17,47,53,91). The importance of this disagreement cannot be understated. If pathologists are going to place identical tumors in different categories, then further analyses of outcomes as they pertain to diagnosis are severely compromised.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aboody K.S., Brown A., Rainov N.G., Bower K.A., Liu S., Yang W., et al. 2000. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc. Natl. Acad. Sci. USA 97:12,846–12,851.

    Article  PubMed  CAS  Google Scholar 

  2. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F.. 2003. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 100:3983–3988.

    Article  PubMed  CAS  Google Scholar 

  3. Alizadeh A.A., Staudt L.M. 2000. Genomic-scale gene expression profiling of normal and malignant immune cells. Curr. Opin. Immunol. 12:219–225.

    Article  PubMed  CAS  Google Scholar 

  4. Alvarez-Buylla A., Garcia-Verdugo J.M. 2002. Neurogenesis in adult subventricular zone. J. Neurosci. 22:629–634.

    PubMed  CAS  Google Scholar 

  5. Appleton R.E., Farrell K., Zaide J., Rogers P. 1990. Decline in head growth and cognitive impairment in survivors of acute lymphoblastic leukaemia. Arch. Dis. Child 65:530–534.

    PubMed  CAS  Google Scholar 

  6. Archibald Y.M., Lunn D, Ruttan L.A., Macdonald D.R., Del Maestro R.F., Barr H.W., et al. 1994. Cognitive functioning in long-term survivors of high-grade glioma. J. Neurosurg. 80:247–253.

    PubMed  CAS  Google Scholar 

  7. Bachoo R.M., Maher E.A., Ligon K.L., Sharpless N.E., Chan S.S., You M.J., et al. 2002. Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell 1:269–277.

    Article  PubMed  CAS  Google Scholar 

  8. Barnett S.C., Robertson L., Graham D., Allan D., Rampling R. 1998. Oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells transformed with c-myc and H-ras form high-grade glioma after stereotactic injection into the rat brain.Carcinogenesis 19:1529–1537.

    Article  PubMed  CAS  Google Scholar 

  9. Bellinzona M., Gobbel G.T., Shinohara C., Fike J.R. 1996. Apoptosis is induced in the subependyma of young adult rats by ionizing irradiation. Neurosci. Lett. 208:163–166.

    Article  PubMed  CAS  Google Scholar 

  10. Benedetti S., Pirola B., Pollo B., Magrassi L., Bruzzone M.G., Rigamonti D., et al. 2000. Gene therapy of experimental brain tumors using neural progenitor cells. Nat. Med. 6:447–450.

    Article  PubMed  CAS  Google Scholar 

  11. Benes F.M., Turtle M., Khan Y., Farol P. 1994. Myelination of a key relay zone in the hippocampal formation occurs in the human brain during childhood, adolescence and adulthood. Arch. Gen. Psychiat. 51: 477–484.

    PubMed  CAS  Google Scholar 

  12. Berens M.E., Giese A. 1999. “...those left behind.” Biology and oncology of invasive glioma cells. Neoplasia 1: 208–219.

    Article  PubMed  CAS  Google Scholar 

  13. Bigner S.H., Bullard D.E., Pegram C.N., Wikstrand C.J., Bigner D.D.. 1981. Relationship of in vitro morphologic and growth characteristics of established human glioma-derived cell lines to their tumorigenicity in athymic nude mice. J. Neuropathol. Exp. Neurol. 40:390–409.

    Article  PubMed  CAS  Google Scholar 

  14. Bouvier C., Bartoli C., Aguirre-Cruz L., Virard I., Colin C., Fernandez C., et al. 2003. Shared oligodendrocyte lineage gene expression in gliomas and oligodendrocyte progenitor cells. J. Neurosurg. 99: 344–350.

    PubMed  CAS  Google Scholar 

  15. Brezden C.B., Phillips K.A., Abdolell M., Bunston T., Tannock I.F. 2000. Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J. Clin. Oncol. 18:2695–2701.

    PubMed  CAS  Google Scholar 

  16. Brown M.S., Stemmer S.M., Simon J.H., Stears J.C., Jones R.B., Cagnoni P.J., Sheeder J.L. 1998. White matter disease induced by high-dose chemotherapy: longitudinal study with MR imaging and proton spectroscopy. AJNR Am. J. Neuroradiol. 19:217–221.

    PubMed  CAS  Google Scholar 

  17. Bruner J.M., Inouye L., Fuller G.N., Langford L.A. 1997. Diagnostic discrepancies and their clinical impact in a neuropathology referral practice. Cancer 79: 796–803.

    Article  PubMed  CAS  Google Scholar 

  18. Cairncross J.G., Ueki K., Zlatescu M.C., Lisle D.K., Finkelstein D.M., Hammond R.R., et al. 1998. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J. Natl. Cancer Inst. 90:1473–1479.

    Article  PubMed  CAS  Google Scholar 

  19. Cetingul N., Aydinok Y., Kantar M., Oniz H., Kavakli K., Yalman O., et al. 1999. Neuropsychologic sequelae in the long-term survivors of childhood acute lymphoblastic leukemia. Pediatr. Hematol. Oncol. 16:213–220.

    Article  PubMed  CAS  Google Scholar 

  20. Cleeland C.S., Mendoza T.R., Wang X.S., Chou C., Harle M.T., Morrissey M., Engstrom M.C.. 2000. Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer 89: 1634–1646.

    Article  PubMed  CAS  Google Scholar 

  21. Coons S.W., Johnson P.C., Shapiro J.R.. 1995. Cytogenetic and flow cytometry DNA analysis of regional heterogeneity in a low grade human glioma. Cancer Res. 55:1569–1577.

    PubMed  CAS  Google Scholar 

  22. Dai C., Celestino J.C., Okada Y., Louis D.N., Fuller G.N., Holland E.C.. 2001. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev. 15:1913–1925.

    Article  PubMed  CAS  Google Scholar 

  23. Ding H., Roncari L., Shannon P., Wu X., Lau N., Karaskova J., et al. 2001. Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas. Cancer Res. 61:3826–3836.

    PubMed  CAS  Google Scholar 

  24. Ding H., Shannon P., Lau N., Wu X., Roncari L., Baldwin R.L., et al. 2003. Oligodendrogliomas result from the expression of an activated mutant epidermal growth factor receptor in a RAS transgenic mouse astrocytoma model. Cancer Res. 63:1106–1113.

    PubMed  CAS  Google Scholar 

  25. Doetsch F., Caille I., Lim D.A., Garcia-Verdugo J.M., Alvarez-Buylla A. 1999. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 97:703–716.

    Article  PubMed  CAS  Google Scholar 

  26. Donahue B., Scott C.B., Nelson J.S., Rotman M., Murray K.J., Nelson D.F., et al. 1997. Influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas: a report of Radiation Therapy Oncology Group 83-02. Int. J. Radiat. Oncol. Biol. Phys. 38:911–914.

    PubMed  CAS  Google Scholar 

  27. Duelli D., Lazebnik Y. 2003. Cell fusion: A hidden enemy? Cancer Cell 3:445–448.

    Article  PubMed  CAS  Google Scholar 

  28. Eriksson P.S., Perfilieva E., Bjork-Eriksson T., Alborn A.M., Nordborg C., Peterson D.A., Gage F.H. 1998. Neurogenesis in the adult human hippocampus. Nat. Med. 4:1313–1317.

    Article  PubMed  CAS  Google Scholar 

  29. Espinosa de los Monteros A., Zhang M., De Vellis J. 1993. O2A progenitor cells transplanted into the neonatal rat brain develop into oligodendrocytes but not astrocytes. Proc. Natl. Acad. Sci. USA 90: 50–54.

    Article  PubMed  CAS  Google Scholar 

  30. Feldkamp M.M., Lala P., Lau N., Roncari L., Guha A. 1999. Expression of activated epidermal growth factor receptors, Ras-guanosine triphosphate, and mitogen-activated protein kinase in human glioblastoma multiforme specimens. Neurosurgery 45:1442–1453.

    Article  PubMed  CAS  Google Scholar 

  31. Fok-Seang J., Miller H.R. 1992. Astrocyte precursors in neonatal rat spinal cord cultures. J. Neurosci. 12:2751–2764.

    PubMed  CAS  Google Scholar 

  32. Fok-Seang J., Miller R.H. 1994. Distribution and differentiation of A2B5+ glial precursors in the developing rat spinal cord. J. Neurosci. Res. 37:219–235.

    Article  PubMed  CAS  Google Scholar 

  33. Foran D.R., Peterson A.C. 1992. Myelin acquisition in the central nervous system of the mouse revealed by an MBP-LacZ transgene. J. Neurosci. 12:4890–4897.

    PubMed  CAS  Google Scholar 

  34. Glauser T.A., Packer R.J. 1991. Cognitive deficits in long-term survivors of childhood brain tumors. Childs Nerv. Syst. 7:2–12.

    Article  PubMed  CAS  Google Scholar 

  35. Gregor A., Cull A., Traynor E., Stewart M., Lander F., Love S. 1996. Neuropsychometric evaluation of long-term survivors of adult brain tumours: relationship with tumour and treatment parameters. Radiother. Oncol. 41:55–59.

    PubMed  CAS  Google Scholar 

  36. Gregori N., Pröschel C., Noble M., Mayer-Pröschel M. 2002. The tripotential glial-restricted precursor (GRP) cell and glial development in the spinal cord: Generation of bipotential oligodendrocyte-type-2 astrocyte progenitor cells and dorsal-ventral differences in GRP cell function. J. Neurosci. 22: 248–256.

    PubMed  CAS  Google Scholar 

  37. Grill J., Renaux V.K., Bulteau C., Viguier D., Levy-Piebois C., Sainte-Rose C., et al. 1999. Long-term intellectual outcome in children with posterior fossa tumors according to radiation doses and volumes. Int. J. Radiat. Oncol. Biol. Phys. 45:137–145.

    PubMed  CAS  Google Scholar 

  38. Grinspan J.B., Stern J.L., Pustilnik S.M., Pleasure D. 1990. Cerebral white matter contains PDGF-responsive precursors to O2A cells. J. Neurosci. 10:1866–1873.

    PubMed  CAS  Google Scholar 

  39. Herrera J., Yang H., Zhang S.C., Proschel C., Tresco P., Duncan I.D., et al. 2001. Embryonic-derived glial-restricted precursor cells (GRP cells) can differentiate into astrocytes and oligodendrocytes in vivo. Exp. Neurol. 171:11–21.

    Article  PubMed  CAS  Google Scholar 

  40. Hesselager G., Holland E.C.. 2003. Using mice to decipher the molecular genetics of brain tumors. Neurosurgery 53: 685–694.

    Article  PubMed  Google Scholar 

  41. Hopewell J.W., van der Kogel A.J. 1999. Pathophysiological mechanisms leading to the development of late radiationinduced damage to the central nervous system. Front Radiat. Ther. Oncol. 33:265–275.

    Article  PubMed  CAS  Google Scholar 

  42. Ignatova T.N., Kukekov V.G., Laywell E.D., Suslov O.N., Vrionis F.D., Steindler D.A. 2002. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 39: 193–206.

    Article  PubMed  Google Scholar 

  43. Kalyani A., Piper D., Mujitaba T., Lucero M., Rao M. 1998. E-NCAM immunoreactive neuronal precursor cells differentiate into multiple neurotransmitter phenotypes. J. Neurosci. 18:7856–7868.

    PubMed  CAS  Google Scholar 

  44. Keime-Guibert F., Napolitano M., Delattre J.Y. 1998. Neurological complications of radiotherapy and chemotherapy. J. Neurol. 245:695–708.

    Article  PubMed  CAS  Google Scholar 

  45. Kennedy P.G., Watkins B.A., Thomas D.G., Noble M.D. 1987. Antigenic expression by cells derived from human gliomas does not correlate with morphological classification. Neuropathol. Appl. Neurobiol. 13:327–347.

    Article  PubMed  CAS  Google Scholar 

  46. Kinney H.C., Brody B.A., Kloman A.S., Gilles F.H. 1988. Sequence of central nervous sytem myelination in human infancy. II. Patterns of myelination in autopsied infants. J. Neuropath. Exp. Neurol. 47: 217–234.

    Article  PubMed  CAS  Google Scholar 

  47. Kraus J.A., Wenghoefer M., Schmidt M.C., von Deimling A., Berweiler U., Roggendorf W., et al. 2000. Long-term survival of glioblastoma multiforme: importance of histopathological reevaluation. J. Neurol. 247:455–460.

    Article  PubMed  CAS  Google Scholar 

  48. Lamborn K.R., Prados M.D., Kaplan S.B., Davis R.L. 1999. Final report on the University of California-San Francisco experience with bromodeoxyuridine labeling index as a prognostic factor for the survival of glioma patients. Cancer 85:925–935.

    Article  PubMed  CAS  Google Scholar 

  49. Larizza L., Schirrmacher V., Pfluger E. 1984. Acquisition of high metastatic capacity after in vitro fusion of a nonmetastatic tumor line with a bone marrow-derived macrophage. J. Exp. Med. 160:1579–1584.

    Article  PubMed  CAS  Google Scholar 

  50. Lee J.C., Mayer-Proschel M, Rao M.S. 2000. Gliogenesis in the central nervous system. Glia 30:105–121.

    Article  PubMed  CAS  Google Scholar 

  51. Li Y.Q., Wong C.S. 1998. Apoptosis and its relationship with cell proliferation in the irradiated rat spinal cord. Int. J. Radiat. Biol. 74:405–417.

    Article  PubMed  CAS  Google Scholar 

  52. Loeper S., Romeike B.F., Heckmann N., Jung V., Henn W., Feiden W., et al. 2001. Frequent mitotic errors in tumor cells of genetically micro-heterogeneous glioblastomas. Cytogenet. Cell Genet. 94:1–8.

    Article  PubMed  CAS  Google Scholar 

  53. Louis D.N., Gusella J.F.. 1995. A tiger behind many doors: multiple genetic pathways to malignant glioma. Trends Genet. 11:412–415.

    Article  PubMed  CAS  Google Scholar 

  54. Lu Q.R., Park J.K., Noll E., Chan J.A., Alberta J., Yuk D., et al. 2001. Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors. Proc. Natl. Acad. Sci. USA 98:10,851–10,856.

    Article  PubMed  CAS  Google Scholar 

  55. Macklin W.B., Weill C.L. 1985. Appearance of myelin proteins during development in the chick central nervous system. Dev. Neurosci. 7:170–178.

    Article  PubMed  CAS  Google Scholar 

  56. Marie Y., Sanson M., Mokhtari K., Leuraud P., Kujas M., Delattre J.Y., et al. 2001. OLIG2 as a specific marker of oligodendroglial tumour cells. Lancet 358:298–300.

    Article  PubMed  CAS  Google Scholar 

  57. Mason W., Louis D.N., Cairncross J.G. 1997. Chemosensitive gliomas in adults: which ones and why? J. Clin. Oncol. 15:3423–3426.

    PubMed  CAS  Google Scholar 

  58. Mayer-Pröschel M., Kalyani A., Mujtaba T., Rao M.S. 1997. Isolation of lineage-restricted neuronal precursors from multipotent neuroepithelial stem cells. Neuron. 19:773–785.

    Article  PubMed  Google Scholar 

  59. McDermott M.W., Krouwer H.G., Asai A., Ito S., Hoshino T., Prados M.D. 1992. A comparison of CT contrast enhancement and BUDR labeling indices in moderately and highly anaplastic astrocytomas of the cerebral hemispheres. Can. J. Neurol. Sci. 19:34–39.

    PubMed  CAS  Google Scholar 

  60. McKay R. 1997. Stem cells in the central nervous system. Science 276:66–71.

    Article  PubMed  CAS  Google Scholar 

  61. Mi H., Barres B.A. 1999. Purification and characterization of astrocyte precursor cells in the developing rat optic nerve. J. Neurosci. 19:1049–1061.

    PubMed  CAS  Google Scholar 

  62. Misra A., Chattopadhyay P., Dinda A.K., Sarkar C., Mahapatra A.K., Hasnain S.E., Sinha S. 2000. Extensive intratumor heterogeneity in primary human glial tumors as a result of locus non-specific genomic alterations. J. Neurooncol. 48:1–12.

    Article  PubMed  CAS  Google Scholar 

  63. Moe P.J., Holen A. 2000. High-dose methotrexate in childhood all. Pediatr.Hematol. Oncol. 17:615–622.

    Article  Google Scholar 

  64. Morris G.M., Hopewell J.W., Morris A.D. 1995. A comparison of the effects of methotrexate and misonidazole on the germinal cells of the subependymal plate of the rat. Br. J. Radiol. 68:406–412.

    Article  PubMed  CAS  Google Scholar 

  65. Mueller W., Hartmann C., Hoffmann A., Lanksch W., Kiwit J., Tonn J., et al. 2002. Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets. Am. J. Pathol. 161: 313–319.

    PubMed  CAS  Google Scholar 

  66. Nagane M., Coufal F., Lin H., Bogler O., Cavenee W., Huang H. 1996. A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis. Cancer Res. 56:5079–5086.

    PubMed  CAS  Google Scholar 

  67. Nagane M., Coufal F., Lin H., Bogler O., Cavenee W.K., Huang H.J. 1996. A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis. Cancer Res. 56:5079–5086.

    PubMed  CAS  Google Scholar 

  68. Nagane M., Levitzki A., Gazit A., Cavenee W.K., Huang H.J. 1998. Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases. Proc. Natl. Acad. Sci. USA 95:5724–5729.

    Article  PubMed  CAS  Google Scholar 

  69. Nishiyama A., Chang A., Trapp B.D. 1999. NG2+ glial cells: a novel glial cell population in the adult brain. J. Neuropathol. Exp. Neurol. 58:1113–1124.

    Article  PubMed  CAS  Google Scholar 

  70. Noble M. 2000. Can neural stem cells be used as therapeutic vehicles in the treatment of brain tumors? Nat. Med. 6:369–370.

    Article  PubMed  CAS  Google Scholar 

  71. Noble M. 2000. Can neural stem cells be used to track down and destroy migratory brain tumor cells while also providing a means of repairing tumor-associated damage? Proc. Natl. Acad. Sci. USA 97:12,393–12,395.

    Article  PubMed  CAS  Google Scholar 

  72. Noble M., Dietrich J. 2004. The complex identity of brain tumors: emerging concerns regarding origin, diversity and plasticity. Trends Neurosci. 27:148–154.

    Article  PubMed  CAS  Google Scholar 

  73. Noble M., Murray K. 1984. Purified astrocytes promote the in vitro division of a bipotential glial progenitor cell. EMBO-J. 3:2243–2247.

    PubMed  CAS  Google Scholar 

  74. Noble M., Murray K., Stroobant P., Waterfield M.D., Riddle P. 1988. Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell. Nature 333:560–562.

    Article  PubMed  CAS  Google Scholar 

  75. Noble M., Pröschel C., Mayer-Proschel M. 2004. Getting a GR(i)P on oligodendrocyte development. Dev. Biol. 265:33–52.

    Article  PubMed  CAS  Google Scholar 

  76. Nutt C.L., Noble M., Chambers A.F., Cairncross J.G. 2000. Differential expression of drug resistance genes and chemosensitivity in glial cell lineages correlate with differential response of oligodendrogliomas and astrocytomas to chemotherapy. Cancer Res. 60:4812–4818.

    PubMed  CAS  Google Scholar 

  77. Onda K., Davis R.L., Shibuya M., Wilson C.B., Hoshino T. 1994. Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas. Cancer 74: 1921–1926.

    Article  PubMed  CAS  Google Scholar 

  78. Peissner W., Kocher M., Treuer H., Gillardon F. 1999. Ionizing radiation-induced apoptosis of proliferating stem cells in the dentate gyrus of the adult rat hippocampus. Brain Res. Mol. Brain Res. 71:61–68.

    Article  PubMed  CAS  Google Scholar 

  79. Pomeroy S.L., Tamayo P., Gaasenbeek M., Sturla L.M., Angelo M., McLaughlin M.E., et al. 2002. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415:436–442.

    Article  PubMed  CAS  Google Scholar 

  80. Power J., Mayer-Proschel M., Smith J., Noble M. 2002. Oligodendrocyte precursor cells from different brain regions express divergent properties consistent with the differing time courses of myelination in these regions. Dev. Biol. 245:362–375.

    Article  PubMed  CAS  Google Scholar 

  81. Rachkovsky M., Sodi S., Chakraborty A., Avissar Y., Bolognia J., McNiff J.M., et al. 1998. Melanoma x macrophage hybrids with enhanced metastatic potential. Clin. Exp. Metastasis. 16:299–312.

    Article  PubMed  CAS  Google Scholar 

  82. Radcliffe J., Bunin G.R., Sutton L.N., Goldwein J.W., Phillips P.C. 1994. Cognitive deficits in long-term survivors of childhood medulloblastoma and other noncortical tumors: age-dependent effects of whole brain radiation. Int. J. Dev. Neurosci. 12:327–334.

    Article  PubMed  CAS  Google Scholar 

  83. Raff M.C., Miller R.H., Noble M. 1983. A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on the culture medium. Nature 303:390–396.

    Article  PubMed  CAS  Google Scholar 

  84. Rao M., Mayer-Pröschel M. 1997. Glial restricted precursors are derived from multipotent neuroepithelial stem cells. Dev. Biology 188:48–63.

    Article  CAS  Google Scholar 

  85. Rao M., Noble M., Mayer-Pröschel M. 1998. A tripotential glial precursor cell is present in the developing spinal cord. Proc. Natl. Acad. Sci. USA 95:3996–4001.

    Article  PubMed  CAS  Google Scholar 

  86. Reynolds B.A., Tetzlaff W., Weiss S. 1992. A Mulitpotent EGF-Responsive Striatal Embryonic Progenitor Cell Produces Neurons and Astrocytes. J. Neuroscience 12:4565–4574.

    CAS  Google Scholar 

  87. Reynolds B.A., Weiss S. 1992. Generation of neurons and astrocytes from isolated cells of the adult mammalian cental nervous system. Science 225:1707–1710.

    Article  Google Scholar 

  88. Reynolds B.A., Weiss S. 1996. Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell. Dev. Biol. 175:1–13.

    Article  PubMed  CAS  Google Scholar 

  89. Riva D., Giorgi C. 2000. The neurodevelopmental price of survival in children with malignant brain tumours. Childs Nerv. Syst. 16:751–754.

    Article  PubMed  CAS  Google Scholar 

  90. Roman D.D., Sperduto P.W. 1995. Neuropsychological effects of cranial radiation: current knowledge and future directions. Int. J. Radiat. Oncol. Biol. Phys. 31:983–998.

    PubMed  CAS  Google Scholar 

  91. Rorke L.B. 1997. Pathologic diagnosis as the gold standard. Cancer 79:665–667.

    Article  PubMed  CAS  Google Scholar 

  92. Rubnitz J.E. 2000. Molecular diagnostics in the treatment of childhood acute lymphoblastic leukemia. J. Biol. Regul. Homeost. Agents 14:182–186.

    PubMed  CAS  Google Scholar 

  93. Salander P., Karlsson T., Bergenheim T., Henriksson R. 1995. Long-term memory deficits in patients with malignant gliomas. J. Neurooncol. 25:227–238.

    Article  PubMed  CAS  Google Scholar 

  94. Schagen S.B., Muller M.J., Boogerd W., Lindeboom J.. 1999. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 85:640–650.

    Article  PubMed  CAS  Google Scholar 

  95. Schlegel U., Pels H., Oehring R., Blumcke I. 1999. Neurologic sequelae of treatment of primary CNS lymphomas. J. Neurooncol. 43:277–286.

    Article  PubMed  CAS  Google Scholar 

  96. Seidman K., Teng A., Rosenkopf R., Spilotro P., Weyhenmeyer J. 1997. Isolation, cloning and characterization of a putative type-1 astrocyte cell line. Brain Res. 753:18–26.

    Article  PubMed  CAS  Google Scholar 

  97. Shapiro J.R., Shapiro W.R.. 1984. Clonal tumor cell heterogeneity. Prog. Exp. Tumor Res. 27:49–66.

    PubMed  CAS  Google Scholar 

  98. Shapiro J.R., Shapiro W.R. 1985. The subpopulations and isolated cell types of freshly resected high grade human gliomas: their influence on the tumor’s evolution in vivo and behavior and therapy in vitro. Cancer Metastasis Rev. 4: 107–124.

    Article  PubMed  CAS  Google Scholar 

  99. Shuangshoti S., Navalitloha Y., Kasantikul V., Shuangshoti S., Mutirangura A. 2000. Genetic heterogeneity and progression in different areas within high-grade diffuse astrocytoma. Oncol. Rep. 7:113–117.

    PubMed  CAS  Google Scholar 

  100. Skoff R.P., Toland D., Nast E. 1980. Pattern of myelination and distribution of neuroglial cells along the developing optic system of the rat and rabbit. J. Comp. Neurol. 191:237–253.

    Article  PubMed  CAS  Google Scholar 

  101. Stemmer S.M., Stears J.C., Burton B.S., Jones R.B., Simon J.H. 1994. White matter changes in patients with breast cancer treated with high-dose chemotherapy and autologous bone marrow support. AJNR Am. J. Neuroradiol. 15: 1267–1273.

    PubMed  CAS  Google Scholar 

  102. Stylopoulos L.A., George A.E., de Leon M.J., Miller J.D., Foo S.H., Hiesiger E., Wise A. 1988. Longitudinal CT study of parenchymal brain changes in glioma survivors. AJNR Am. J. Neuroradiol. 9: 517–522.

    PubMed  CAS  Google Scholar 

  103. Tada E., Parent J.M., Lowenstein D.H., Fike J.R. 2000. X-irradiation causes a prolonged reduction in cell proliferation in the dentate gyrus of adult rats. Neuroscience 99:33–41.

    Article  PubMed  CAS  Google Scholar 

  104. Temple S., Qian X. 1996. Vertebrate neural progenitor cells: subtypes and regulation. Curr. Op. Neurobiol. 6:11–17.

    Article  PubMed  CAS  Google Scholar 

  105. Terada N., Hamazaki T., Oka M., Hoki M., Mastalerz D.M., Nakano Y., et al. 2002. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 416:542–545.

    Article  PubMed  CAS  Google Scholar 

  106. Troy L., McFarland K., Littman-Power S., Kelly B.J., Walpole E.T., Wyld D., Thomson D. 2000. Cisplatin-based therapy: a neurological and neuropsychological review. Psychooncology 9:29–39.

    Article  PubMed  CAS  Google Scholar 

  107. Uhrbom L., Dai C., Celestino J.C., Rosenblum M.K., Fuller G.N., Holland E.C. 2002. Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt. Cancer Res. 62:5551–5518.

    PubMed  CAS  Google Scholar 

  108. van’ t Veer L.J., Dai H., van De Vijver M.J., He Y.D., Hart A.A., Mao M, et al. 2002. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530–536.

    Article  Google Scholar 

  109. van Dam F.S., Schagen S.B., Muller M.J., Boogerd W., vd Wall E., Droogleever Fortuyn M.E., Rodenhuis S. 1998. Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J. Natl. Cancer Inst. 90:210–218.

    Article  PubMed  Google Scholar 

  110. van den Bent M.J. 2000. Chemotherapy of oligodendroglial tumours: current developments. Forum (Genova) 10:108–118.

    Google Scholar 

  111. Vescovi A., Gritti A., Galli R., Parati E. 1999. Isolation and intracerebral grafting of nontransformed multipotential embryonic human CNS stem cells. J. Neurotrauma 16:689–693.

    PubMed  CAS  Google Scholar 

  112. Vigliani M.C., Duyckaerts C., Hauw J.J., Poisson M., Magdelenat H. 1999. Dementia following treatment of brain tumors with radiotherapy administered alone or in combination with nitrosourea-based chemotherapy: a clinical and pathological study. J. Neurooncol. 41:137–149.

    Article  PubMed  CAS  Google Scholar 

  113. Waber D.P., Tarbell N.J. 1997. Toxicity of CNS prophylaxis for childhood leukemia. Oncology (Huntingt) 11:259–264; discussion 264–265.

    CAS  Google Scholar 

  114. Wacker M.R., Hoshino T., Ahn D.K., Davis R.L., Prados M.D. 1994. The prognostic implications of histologic classification and bromodeoxyuridine labeling index of mixed gliomas. J. Neurooncol. 19: 113–122.

    Article  PubMed  CAS  Google Scholar 

  115. Wang X., Willenbring H., Akkari Y., Torimaru, Foster M., Al-Dhalimy M., et al. 2003. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 422:897–901.

    Article  PubMed  CAS  Google Scholar 

  116. Weimann J.M., Johansson C.B., Trejo A., Blau H.M. 2003. Stable reprogrammed heterokaryons form spontaneously in Purkinje neurons after bone marrow transplant. Nat. Cell Biol. 5:959–966.

    Article  PubMed  CAS  Google Scholar 

  117. Weiss S., Dunne C., Hewson J., Wohl C., Wheatley M., Peterson A.C., Reynolds B.A. 1996. Multipotent CNS Stem Cells are Present in the Adult Mammalian Spinal Cord and Ventricular Neuroaxis. J. Neurosci. 16: 7599–7609.

    PubMed  CAS  Google Scholar 

  118. Weiss W.A., Burns M.J., Hackett C., Aldape K., Hill J.R., Kuriyama H., et al. 2003. Genetic determinants of malignancy in a mouse model for oligodendroglioma. Cancer Res. 63:1589–1595.

    PubMed  CAS  Google Scholar 

  119. Westphal M., Nausch H., Herrmann H.D. 1990. Antigenic staining patterns of human glioma cultures: primary cultures, long-term cultures and cell lines. J. Neurocytol. 19:466–477.

    Article  PubMed  CAS  Google Scholar 

  120. Wolswijk G., Noble M. 1989. Identification of an adult-specific glial progenitor cell. Development 105:387–400.

    PubMed  CAS  Google Scholar 

  121. Wolswijk G., Noble M. 1992. Cooperation between PDGF and FGF converts slowly dividing O-2Aadult progenitor cells to rapidly dividing cells with characteristics of O-2Aperinatal progenitor cells. J. Cell. Biol. 118:889–900.

    Article  PubMed  CAS  Google Scholar 

  122. Wolswijk G., Riddle P.N., Noble M. 1991. Platelet-derived growth factor is mitozgenic for O-2Aadult progenitor cells. Glia 4:495–503.

    Article  PubMed  CAS  Google Scholar 

  123. Wren D., Wolswijk G., Noble M. 1992. In vitro analysis of the origin and maintenance of O-2Aadult progenitor cells. J. Cell. Biol. 116:167–176.

    Article  PubMed  CAS  Google Scholar 

  124. Yakovlev P.L., Lecours A.R. 1967. The myelogenetic cycles of regional maturation of the brain, in Regional development of the brain in early life ( Minkowski A., et. al., ed.), Blackwell, Oxford. p. 3–70.

    Google Scholar 

  125. Ying Q.L., Nichols J., Evans E.P., Smith A.G.. 2002. Changing potency by spontaneous fusion. Nature 416:545–548.

    Article  PubMed  CAS  Google Scholar 

  126. Zlatescu M.C., TehraniYazdi A., Sasaki H., Megyesi J.F., Betensky R.A., Louis D.N., Cairncross J.G. 2001. Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms. Cancer Res. 61:6713–6715.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY

    Mark Noble PhD & Joerg Dietrich MD

Authors
  1. Mark Noble PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joerg Dietrich MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Surgery, Duke University Medical Center, Durham, NC

    Francis Ali-Osman DSc

  2. Comprehensive Cancer Center, Duke University Medical Center, Durham, NC

    Francis Ali-Osman DSc

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Noble, M., Dietrich, J. (2005). Analysis of Neural Precursor Cells in the Context of Origin of Brain Tumors, Their Treatment, and Repair of Treatment-Associated Damage. In: Ali-Osman, F. (eds) Brain Tumors. Contemporary Cancer Research. Humana Press. https://doi.org/10.1385/1-59259-843-9:107

Download citation

Publish with us

Policies and ethics

Search

Navigation